7 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 4 with minor changes only.
Primary and study completion pushed from May 28, 2031 to Dec 31, 2031
Also in this update: Trial arms changed: 1 → 2
BiogenPhase 3 NCT07444489 Registry history of NCT07444489 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Mar 29, 2030 to May 3, 2032
BiogenPhase 3 NCT05352919 Registry history of NCT05352919 on ClinicalTrials.gov (opens the registry)
Recruitment opened
Also in this update: Start date changed from estimate of Oct 22, 2026 to Oct 7, 2026
BiogenPhase 1/2 NCT07855211 Registry history of NCT07855211 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
BiogenPhase 3 NCT06953583 Registry history of NCT06953583 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 8 → 11 locations
BiogenPhase 2 NCT07722546 Registry history of NCT07722546 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 45 → 48 locations
BiogenPhase 2 NCT07219043 Registry history of NCT07219043 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 261 → 264 locations
BiogenPhase 3 NCT06935357 Registry history of NCT06935357 on ClinicalTrials.gov (opens the registry)
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-02 | NCT07855211 A Study to Learn About the Safety of BIIB147 and Its Effects in Adults With Amyotrophic… | Phase 1/2 | Recruiting |
| Phase 1 | 6 | |
| Phase 1/2 | 1 | |
| Phase 2 | 3 | |
| Phase 2/3 | 1 | |
| Phase 3 | 16 | |
| Phase 4 | 1 |
Spinal Muscular Atrophy (10) · Multiple Sclerosis (6) · Lupus (SLE) (5) · ALS (4) · Alzheimer's Disease (1) · Dementia (1) · Depression (1) · Postpartum Depression (1)